Finzati - Logo
ASTH logo

Astrana Health, Inc.

ASTH • Medical - Care Facilities
$38.47
▲ +0.64 (+1.69%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.91B
Growth
-75.5%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 38.4%Positive free cash flow · 2.13Consistent free cash flow · 5/5Healthy liquidity · 1.4Expensive earnings multiple · 54.15
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$38.47
Change1.69%
Shares Out49.78M
Market Cap$1.91B
Enterprise Value$2.45B
52W Range18.08 - 51.60
Beta0.90
P/E47.23
P/S0.50
P/B2.31
P/FCF12.09
EV/Sales0.64

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Positive revenue growth · 38.4%Positive free cash flow · 2.13Consistent free cash flow · 5/5Healthy liquidity · 1.4Expensive earnings multiple · 54.15Weak profitability

Analyst view

Analyst sentiment and price target

ASTH
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
100/100
Bullish
Bullish
10
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$41.00
Mean
$51.80
Median
$53.00
High
$65.00

Company Overview

IPO: 3/11/2009
Industry: Medical - Care Facilities
P/B i: 2.31
Debt / Equity i: 1.38
Operating Margin: 2.47%
Net Margin: 0.71%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 1.38
Current Ratio: 1.40
Quick Ratio: 1.40
Status: Good

Insider Transactions

Recent executive and insider activity

Sobotka Glenn
Transaction: 08/07/2026
SELL
Change
-11,793
Price
Not reported
Filing
08/11/2026
Type
SELL
Vong John
Transaction: 08/07/2026
OTHER
Change
0
Price
Not reported
Filing
08/11/2026
Type
OTHER
Sim Brandon
Transaction: 06/27/2026
SELL
Change
-1,093
Price
$44.51
Filing
06/30/2026
Type
SELL